Aptevo Therapeutics Changes Auditors
Ticker: APVO · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
Related Tickers: APVO
TL;DR
APVO switched auditors from CohnReznick to BDO USA, P.A. effective June 20, 2025.
AI Summary
Aptevo Therapeutics Inc. filed an 8-K on June 23, 2025, to report changes in its certifying accountant. The company has appointed BDO USA, P.A. as its new independent registered public accounting firm, effective June 20, 2025. This change follows the resignation of their previous auditor, CohnReznick LLP.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.
Risk Assessment
Risk Level: low — This filing pertains to a routine administrative change in the company's auditors and does not involve significant financial or operational developments.
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- BDO USA, P.A. (company) — New Certifying Accountant
- CohnReznick LLP (company) — Former Certifying Accountant
- June 23, 2025 (date) — Filing Date
- June 20, 2025 (date) — Effective Date of Auditor Change
FAQ
Who is Aptevo Therapeutics Inc.'s new independent registered public accounting firm?
Aptevo Therapeutics Inc. has appointed BDO USA, P.A. as its new independent registered public accounting firm.
When was the change in certifying accountant effective?
The change in certifying accountant was effective June 20, 2025.
Who was Aptevo Therapeutics Inc.'s previous independent registered public accounting firm?
Aptevo Therapeutics Inc.'s previous independent registered public accounting firm was CohnReznick LLP.
What is the filing date of this 8-K report?
This 8-K report was filed on June 23, 2025.
Did the company have any disagreements with its former accountant on accounting and financial disclosure matters?
The filing does not mention any disagreements with the former accountant, CohnReznick LLP, on accounting and financial disclosure matters.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Aptevo Therapeutics Inc. (APVO).